Celltrion Holdings to cease selling shares internationally
Published: 02 Jul. 2014, 21:08
The company pushed for an M&A in an effort to boost competitiveness in the global market, but the decision will become a shift in its marketing strategy, choosing to strengthen its sales network overseas.
The company’s foreign investors made the decision because they concluded that the M&A may raise financial uncertainties at a time when its stronghold biosimilar product Remsima is selling well in Europe.
with the Korea JoongAng Daily
To write comments, please log in to one of the accounts.
Standards Board Policy (0/250자)